Myocardial infarction (MI) is a common cardiovascular disease that seriously endangers
human health and complex pathophysiology (eg, coronary artery obstruction, myocardial …

Substantial advancements have been achieved in the realm of cardiac tissue repair utilizing
functional hydrogel materials. Additionally, drug-loaded hydrogels have emerged as a …

Localized administration of anti-inflammatory agents benefits patients after myocardial
infarction (MI) by repressing/modulating inflammatory response of the MI region and thus …

Current treatments including drug therapy, medical device implantation, and organ
transplantation have considerable shortcomings for myocardial infarction (MI), such as high …

Dedifferentiation and proliferation of endogenous cardiomyocytes in situ can effectively
improve cardiac repair following myocardial infarction (MI). 6-Bromoindirubin-3-oxime (BIO) …

Abstract Ischemia-reperfusion (I/R)-induced organ injury is a serious health problem
worldwide, and poor recovery of acute phase injury leads to chronic fibrosis and further …

Injectable hydrogels have emerged as a promising strategy for the treatment of myocardial
infarction (MI) by delivering therapeutic cargo factors to modulate the infarct …

Drug-loaded hydrogels can improve blood supply and inhibit extracellular matrix
degradation after myocardial infarction. However, due to the continual dynamic motion of …

In recent years, engineered cardiac patch (ECP) with electrical conductivity has been
developed for cardiac repair after injury or infarction. However, the application of traditional …

Myocardial infarction (MI) is the leading cause of cardiovascular disease-related deaths.
Local ischemia and cardiomyocyte death lead to a series of pathological remodeling events …